Latuda (cobicistat / darunavir)
Prezcobix 800 MG / 150 MG Oral Tablet
NO BOXED WARNING

Dosage & Administration

Dosage & Administration

Recommended dosage:One tablet taken once daily with food in adults and pediatric patients weighing at least 40 kg. ( 2.1)

Testing Prior to Initiation:HIV genotypic testing is recommended for antiretroviral treatment experienced patients. Assess estimated creatinine clearance in all patients prior to starting PREZCOBIX. When used with tenofovir DF: Assess urine glucose and urine protein at baseline and monitor creatinine clearance, urine glucose, and urine protein. Monitor serum phosphorus in patients with or at risk for renal impairment. ( 2.2)

drug label

Latuda Prescribing Information

financial assistance

Latuda Financial Assistance Options

Copay savings program

Enroll in Patients Savings Program
Learn More

patient education

Latuda Patient Education

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

About Latuda: Bipolar Depression
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure: Bipolar Depression
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Doctor Discussion Guide: Bipolar Depression
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

people also ask

Latuda FAQs

How is the dosage of Latuda ?Prezcobix is available in 1 dosages, including 150-800 mg Tab
What does Latuda treat?Prezcobix treats Acquired Immunodeficiency Syndrome and HIV Infections
What is Latuda made of?Prezcobix contains cobicistat / darunavir which is a Cytochrome P450 3A Inhibitor
How Is Latuda Administered?Prezcobix is administered as a Oral Pill
What Are The Latuda Mechanism Of Action?Prezcobix mechanism of action is Breast Cancer Resistance Protein Inhibitors, Cytochrome P450 2D6 Inhibitors, Cytochrome P450 3A Inhibitors, HIV Protease Inhibitors, Multidrug and Toxin Extrusion Transporter 1 Inhibitors, Organic Anion Transporting Polypeptide 1B1 Inhibitors, Organic Anion Transporting Polypeptide 1B3 Inhibitors or P-Glycoprotein Inhibitors
FAQ Data Source